Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Jan;10(1):174-6.
doi: 10.1128/cdli.10.1.174-176.2003.

Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients

Affiliations
Comparative Study

Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients

C J Bax et al. Clin Diagn Lab Immunol. 2003 Jan.

Abstract

New serological enzyme immunoassays (EIAs) were compared with microimmunofluorescence (MIF) as a "gold standard" to detect Chlamydia trachomatis antibodies in different groups of obstetrical, gynecological, and subfertile patients. There were no significant differences in seroprevalence rates, except for the group of C. trachomatis-positive patients (P < 0.01). Test characteristics were calculated for Chlamydia-EIA (Biologische Analysensystem GmbH, Lich, Germany) and pELISA (Medac, Wedel, Germany). pELISA seems to be a good alternative to MIF. It has high specificity and is easier to perform.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clad, A., H. Freidank, J. Plünnecke, B. Jung, and E. E. Petersen. 1994. Chlamydia trachomatis species-specific serology: ImmunoComb Chlamydia Bivalent versus microimmunofluorescence (MIF). Infection 22:165-173. - PubMed
    1. Clad, A., H. M. Freidank, M. Kunze, U. Schnoeckel, S. Hofmeier, U. Flecken, and E. E. Petersen. 2000. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur. J. Clin. Microbiol. Infect. Dis. 19:932-937. - PubMed
    1. Gijsen, A. P., J. A. Land, V. J. Goossens, P. Leffers, C. A. Bruggeman, and J. L. H. Evers. 2001. Chlamydia pneumoniae and screening for tubal factor subfertility. Hum. Reprod. 16:487-491. - PubMed
    1. Gijsen, A. P., V. J. Goossens, J. A. Land, J. L. H. Evers, and C. A. Bruggeman. 2000. The predictive value of chlamydia antibody testing (CAT) in screening for tubal factor subfertility: micro-immunofluorescence (MIF) versus ELISA, p.101. In P. Saikku (ed.), Proceedings of the Fourth Meeting of the European Society for Chlamydia Research, Helsinki, Finland.
    1. Johnson, N. P., K. Taylor, A. A. Nadgir, D. J. Chinn, and P. J. Taylor. 2000. Can diagnostic laparoscopy be avoided in routine investigation for infertility? Br. J. Obstet. Gynaecol. 107:174-178. - PubMed

Substances